Diligence memo · auto-generated · as of July 2, 2026
Proxim Diagnostics Corp
Proxim Diagnostics Corp looks fair against its niche peers and is at-risk on financing cadence.
Businessfiled
Proxim Diagnostics Corp operates in Medical Devices, based in Santa Clara.
Sub-sector tags: medical-devices.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Proxim Diagnostics Corp has raised $23M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $18M on 2022-11-22.
Most recent recorded round closed around 2022-11-22.
Valuation (modeled)modeled
Provath models Proxim Diagnostics Corp at approximately $210M (range $40M–$512M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.32× the median modeled value of Series B Medical Devices companies in 2022–2024 (5 peers) — value vs value, same stage and era. Within the normal band (132% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 48 months.
Last raise 3.6 yr ago; this sector typically re-raises about every 16 months.
Past due for a raise versus sector cadence — watch for distress or a bridge.
The last round stepped up 10.5× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 88% of Medical Devices peers (233 compared).
Modeled value ranks above 93% of those peers.
Closest niche peers: Eximis Surgical Inc., EarliTec Diagnostics, Inc., Zenflow, Inc., Htg Molecular Diagnostics, Inc.
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
Overdue for a raise versus sector norm — distress or bridge risk.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.